SEC Form 4 · accession 0001140361-16-055522
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (right-to-buy)F1 | $32.49 | Feb 25, 2016 | A | 302,205 | A | — | Feb 25, 2026 | Common Stock | 302,205 | 302,205 | D |
Explanation of responses
- F1This option vests 25% on February 25, 2017 and in thirty-six equal monthly installments thereafter.